Expert in new drug discovery and development with over 30 years of academy and industrial experience in metabolic disease, virology, inflammation and oncology therapeutic area
Extensive knowledge and experience with a proven track record of target validation, lead optimization, library design, solid-phase synthesis, and novel technology innovation (solid-supported reagents, microwave, SFC, CFT, SMB, and etc.)
Skilled managing in new chemical entity CMO/CDMO manufacturing and non-clinical CRO business
Ph.D. at Texas A&M University, postdoctoral research associate at UC Berkeley, and Sr. Principal Scientist at Roche
Expert in molecular biology and cellular immunology in the area of cancer immunotherapy, autoimmune diseases, and asthma in both pre-clinical and clinical fields (27 years)
Ph.D. at Chicago Medical School and postdoctoral experience at The Scripps Research Institute, Harvard Medical School, Cincinnati Children’s Hospital Medical Center, University of Pittsburgh Cancer Institute
Immuno-oncology drug development in OncoMed Pharmaceutical and Ambrx
4 Different clinical trials in head and neck cancers were initiated based on his recent publications and 20 peer-reviewed publications
VP, Head of mRNA Research and Business Development at ST PHARM
Expert in gene therapy, genetic vaccine design and development in the area of infectious diseases & cancer immunotherapy
Diverse experiences with about 30 years of academy and industry in viral immunology, biotechnology, gene therapy, vaccines (conventional, subunit, recombinant viral vectors, edible etc.), and oligonucleotide therapeutics.
DNA-based gene optimization knowhow and platform patent holding for potent immunogens creation
Ph.D. at North Carolina State University and postdoctoral fellow at U of PENN
